Adcock Reports Slight Growth In A ‘Difficult Market’
Generics Business Sees Supply Challenges And Pricing Pressure
Adcock has made slight progress despite the effect of the current economic climate in South Africa on consumer spending and behavior.
You may also be interested in...
South Africa’s Aspen has made multiple strategic moves, including divesting its Japanese business to Sandoz and selling its local Phekolong Pharmaceuticals South African subsidiary to Laurus Labs, as part of efforts to better position itself in the face of “challenging” market conditions.
The FDA has revealed details of its recent warning letter to Shilpa, which cites the company’s failure to adequately investigate out-of-specification results and complaints as well as to follow written procedures for complaint handling.
Pfizer has reported 80% growth in its global biosimilars business for the third quarter of 2020, on the back of recent oncology launches. Though the company’s sterile injectables saw a slight drop in business, Pfizer’s biopharma business saw 4% growth.